Organigram Holdings | OGI - 现金及等价物



金融业
股票价格
CAD
资产
CAD 521.31M
现金及等价物
CAD 4.29M
销售成本
CAD 43.39M
流动资产
CAD 250.09M
流动负债
CAD 88.75M
债务
CAD 8.2M
EBIT
CAD -9.79M
EBITDA
CAD -4.76M
员工
1.14K
EPS每股收益
CAD -0.01
股本和储备
CAD 371.81M
销售毛利
CAD 16.41M
债务利息支出
CAD 179K
贷款资金
CAD 60.76M
市值
CAD 157.76M
净收入
CAD -921K
营业费用
CAD 69.59M
营业利润
CAD -9.79M
普通股股本
CAD 136.47M
PE价格收益
12.01
税前利润
CAD -921K
销售收入
CAD 59.79M
销售和管理费用
CAD 22.01M
股票
CAD 135.16M
贸易债权人
CAD 73.14M
应收帐款人
CAD 53.39M


现金及等价物 更改 日
Acasti Pharma USD 18.67M 1.81M 2025-12
Akebia Therapeutics USD 155.55M 7.1M 2026-06
Alaunos Therapeutics USD 354K 1.03M 2026-03
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Canopy Growth CAD 364.68M 6.64M 2026-03
Cronos Group USD 467.02M 354.84M 2026-06
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Moderna USD 1.72B 185M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Organon & Co USD 1.13B 16M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Tilray USD 264.83M 43.16M 2025-06
Viatris USD 886.5M 917.7M 2026-06
Xeris Pharmaceuticals USD 121.75M 10M 2026-06